VivoSim Labs, Inc. Deferred Tax Liabilities, Gross
VivoSim Labs, Inc. (VIVS) had Deferred Tax Liabilities, Gross of $117.00 thousand as of 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-07-14
- 2026-03-31: Deferred Tax Liabilities, Gross $117.00K.
- 2025-03-31: Deferred Tax Liabilities, Gross $254.00K.
- 2024-03-31: Deferred Tax Liabilities, Gross $393.00K.
- 2023-03-31: Deferred Tax Liabilities, Gross $504.00K.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2026-03-31 | $117.00K 10-K · filed 2026-07-14 |
| 2025-03-31 | $254.00K 10-K · filed 2026-07-14 |
| 2024-03-31 | $393.00K 10-K · filed 2025-06-05 |
| 2023-03-31 | $504.00K 10-K · filed 2024-05-31 |
| 2022-03-31 | $695.00K 10-K · filed 2023-07-14 |
| 2021-03-31 | $7.00K 10-K · filed 2022-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |